The forced swimming test in mice: A suitable model to study antidepressants

Neuromethods

Volumn 42, Issue , 2009, Pages 85-118

  Hascoët, Martine ^a   Bourin, Michel ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Animal model; Antidepressants; Forced swimming test; Mice

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CEVADINE; CITALOPRAM; COMPLEMENT COMPONENT C1S; DESIPRAMINE; DOPAMINE; IMIPRAMINE; IPRINDOLE; LAMOTRIGINE; LITHIUM; MEDIFOXAMINE; MIANSERIN; NORADRENALIN; PAROXETINE; PHENYTOIN; SEROTONIN; TOPIRAMATE; VALPROIC ACID;

ANIMAL BEHAVIOR; ANIMAL MODEL; BIPOLAR DISORDER; C57BL MOUSE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DBA 2 MOUSE; DEPRESSION; DIET RESTRICTION; DRUG SENSITIVITY; FORCED SWIMMING TEST; LOCOMOTION; MOUSE; MOUSE STRAIN; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REVIEW; SCREENING TEST; STRAIN DIFFERENCE; SWISS WEBSTER MOUSE;

ANIMALIA; MUS;

EID: 70349819889     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-60761-303-9_6     Document Type: Review

References (110)

1. Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977;229:327-336
2. Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M. Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 1979;57:201-210
3. Petit-Demoulière B, Chenu F, Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl), 2005;177:245-255
4. Borsini F, Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 1988;94:147-160
5. Porsolt RD, Bertin A, Jalfre M. "Behavioural despair" in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 1978;51:291-294
6. West AP. Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry 1990;14:863-877
7. Bourin M. Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests? Fundam Clin Pharmacol 1990;4:49-64.
8. Porsolt RD. Animal models of depression: utility for transgenic research. Rev Neurosci 2000;11:53-58
9. Lucki I, Dalvi A, Mayorga AJ. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) 2001;155:315-322
10. Nestler EJ, Gould E, Manji H, Buncan M, Duman RS, Greshenfeld HK, Hen R, Koester S, Lederhendler I, Meaney M, Robbins T, Winsky L, Zalcman S. Preclinical models: status of basic research in depression. Biol Psychiatry 2002;52:503-528
11. Eisch AJ, Bolanos CA, de Wit J, Simonak RD, Pudiak CM, Barrot M, Verhaagen J, Nestler EJ. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 2003;54:994-1005.
12. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM. Antidepressant-like effect of brainderived neurotrophic factor (BDNF). Pharmacol Biochem Behav 1997;56:131-137
13. Baez M, Volosin M. Corticosterone influences forced swim-induced immobility. Pharmacol Biochem Behav 1994;49:729-736
14. GuoW,ToddK,BourinM,HascoetM,Kouadio F. Additiveeffectsofglyburideandantidepressants in the forced swimming test: evidence for the involvement of potassium channel blockade. PharmacolBiochemBehav 1996;54:725-730
15. Redrobe JP, Pinot P, Bourin M. The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in mice. Fundam Clin Pharmacol 1996;10:524-528
16. Slattery DA, Hudson AL, Nutt DJ. Invited review: the evolution of antidepressant mechanisms. Fundam Clin Pharmacol 2004;18:1-21.
17. Harkin AJ, Bruce KH, Craft B, Paul IA. Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Eur J Pharmacol 1999;372:207-213
18. Khisti RT, Chopde CT, Jain SP. Antidepressant- like effect of the neurosteroid 3alphahydroxy- 5alpha-pregnan-20-one in mice forced swim test. Pharmacol Biochem Behav 2000;67:137-143
19. Gardier AM, Trillat AC, Malagié I, David D, Hascoët M, Colombel MC, Jolliet P, Jacquot C, Hen R, Bourin M. Récepteurs 5- HT1B de la sérotonine et effets antidépresseurs des inhibiteurs de recapture sélectifs de la sérotonine. C.R.Acad.Sci.Paris Life 2001;324:433-441
20. Holmes A, Yang RJ, Murphy DL, Crawley JN. Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 2002;27:914-923
21. Cryan JF, Dalvi A, Jin SH, Hirsch BR, Lucki I, Thomas SA. Use of dopamine-betahydroxylase- deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. J Pharmacol Exp Ther 2001;298:651-657
22. MacQueen GM, Ramakrishnan K, Croll SD, Siuciak JA, Yu G, Young LT, Fahnestock M. Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci 2001;115:1145-1153
23. Monteggia LM, Barrot M, Powell CM, Berton O, Galanis V, Gemelli T, Meuth S, Nagy A, Greene RW, Nestler EJ. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci USA 2004; 20:10827-10832
24. Bourin M, Fiocco AJ, Clenet F. How valuable are animal models in defining antidepressant activity? Hum Psychopharmacol 2001;16:9-21.
25. Dulawa SC, Holick KA, Gundersen B, Hen R. Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 2004;29:1321-1330
26. Bourin M, Colombel MC, Redrobe JP, Nizard J, Hascoët M, Baker GB. Evaluation of efficacies of different classes of antidepressants in the forced swimming test in mice at different ages. Prog Neuropsychopharmacol Biol Psychiatry 1998;22:343-351
27. David DJ, Bourin M, Hascoët M, Colombel MC, Baker GB, Jolliet P. Comparison of antidepressant activity in 4- and 40-weekold male mice in the forced swimming test: involvement of 5-HT1A and 5-HT1B receptors in old mice. Psychopharmacology (Berl) 2001;153:443-449
28. Browne RG. Effects of antidepressants and anticholinergics in a mouse "behavioral despair" test. Eur J Pharmacol 1979;58:331-334
29. Denenberg VH, Talgo NW, Waters NS, Kenner GH. A computer-aided procedure for measuring swim rotation. Physiol Behav 1990;47:1023-1025
30. Dubocovich ML, Mogilnicka E, Areso PM. Antidepressant-like activity of the melatonin receptor antagonist, luzindole (N-0774), in the mouse behavioral despair test. Eur J Pharmacol 1990;182:313-325
31. Sunal R, Gumusel B, Kayaalp SO. Effect of changes in swimming area on results of "behavioral despair test". Pharmacol Biochem Behav 1995;49:891-896
32. Aley KO, Kulkarni SK. GABA-mediated modification of despair behavior in mice. Naunyn Schmiedebergs Arch Pharmacol 1989;339: 306-311
33. Crabbe JC,Wahlsten D, Dudek BC. Genetics of mouse behavior: interactions with laboratory environment. Science 1999;284:1670-1672
34. Cabib S, Orsini C, Le Moal M, Piazza PV. Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience. Science 2000;289:463-465
35. Cabib S, Puglisi-Allegra S, Ventura R. The contribution of comparative studies in inbred strains of mice to the understanding of the hyperactive phenotype. Behav Brain Res 2002;130:103-109
36. Alonso SJ, Castellano MA, Afonso D, Rodriguez M. Sex differences in behavioral despair: relationships between behavioral despair and open field activity. Physiol Behav 1991;49:69-72.
37. David DJ, Nic Dhonnchadha BA, Jolliet P, Hascoët M, Bourin M. Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression? Behav Brain Res 2001;119: 203-211
38. Voikar V, Koks S, Vasar E, Rauvala H. Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav 2001;72:271-281
39. Karolewicz B, Paul IA.Group housing ofmice increases immobility and antidepressant sensitivity in the forced swim and tail suspension tests. Eur J Pharmacol 2001;415:197-201.
40. Hilakivi LA, Ota M, Lister RG. Effect of isolation on brainmonoamines and the behavior of mice in tests of exploration, locomotion, anxiety and behavioral 'despair'. Pharmacol Biochem Behav 1989;33:371-374
41. Yates G, Panksepp J, Ikemoto S, Nelson E, Conner R. Social isolation effects on the "behavioral despair" forced swimming test: effect of age and duration of testing. Physiol Behav 1991;49:347-353
42. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 1997;8:523-532
43. Schramm NL, McDonald MP, Limbird LE. The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. J Neurosci 2001;21:4875-4882
44. Krahe TE, Filgueiras CC, Schmidt SL. Effects of rotational side preferences on immobile behavior of normal mice in the forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:169-176
45. Bai F, Li X, Clay M, Lindstrom T, Skolnick P. Intra- and interstrain differences in models of "behavioral despair". Pharmacol Biochem Behav 2001;70:187-192
46. David DJ, Renard CE, Jolliet P, Hascoët M, Bourin M. Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacology (Berl) 2003;166:373-382 (Pubitemid 36503032)
47. Alcaro A, Cabib S, Ventura R, Puglisi-Allegra S. Genotype- and experience-dependent susceptibility to depressive-like responses in the forced-swimming test. Psychopharmacology (Berl) 2002;164:138-143
48. Arai I, Tsuyuki Y, Shiomoto H, Satoh M, Otomo S. Decreased body temperature dependent appearance of behavioral despair in the forced swimming test in mice. Pharmacol Res 2000;42:171-176
49. Taltavull JF, Chefer VI, Shippenberg TS, Kiyatkin EA. Severe brain hypothermia as a factor underlying behavioral immobility during cold-water forced swim. Brain Res 2003;975:244-247
50. Yoshikawa T, Watanabe A, Ishitsuka Y, Nakaya A, Nakatani N. Identification of multiple genetic loci linked to the propensity for "behavioral despair" in mice. Genome Res 2002;12:357-366
51. Detke MJ, Lucki I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 1996;73:43-46
52. Nomura S, Shimizu J, Kinjo M, Kametani H, Nakazawa T. A new behavioral test for antidepressant drugs. Eur J Pharmacol 1982;83:171-175
53. Raghavendra V, Kaur G, Kulkarni SK. Antidepressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation. Eur Neuropsychopharmacol 2000;10:473-481
54. Easton A, Arbuzova J, Turek FW. The circadian Clock mutation increases exploratory activity and escape-seeking behavior. Genes Brain Behav 2003;2:11-19
55. Holmes A. Mouse Behavioral Models of Anxiety and Depression. In: Crawley JN ed. (ed) Mouse Behavioral Phenotyping. Society for Neuroscience, Washington DC, 2003; 43-47
56. O'Neil MF, Moore NA. Animal models of depression: are there any? Hum Psychopharmacol 2003;18:239-254
57. Wahlsten D, Metten P, Phillips TJ, Boehm SL, 2nd, Burkhart-Kasch S, Dorow J, Doerksen S, Downing C, Fogarty J, Rodd- Henricks K, Hen R, McKinnon CS, Merrill CM, Nolte C, Schalomon M, Schlumbohm JP, Sibert JR, Wenger CD, Dudek BC, Crabbe JC. Different data from different labs: lessons from studies of geneenvironment interaction. J Neurobiol 2003;54:283-311.
58. Andreatini R, Bacellar LF. Animal models: trait or state measure? The test-retest reliability of the elevated plus-maze and behavioral despair. Prog Neuropsychopharmacol Biol Psychiatry 2000;24:549-560
59. Hirani K, Khisti RT, Chopde CT. Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3 alpha-hydroxy-5 alpha-pregnan-20-one. Neuropharmacology 2002;43:1339-1350
60. Steru L, Chermat R, Thierry B, Simon P. The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs. Neuropsychopharmacol Biol Psychiatry 1987;11:659-671
61. Ripoll N, David DJP, Dailly E, Hascoët M, Bourin M. Antidepressant-like effects in various mice strains in the tail suspension test. Behav Brain Res 2003;143:193-200. (Pubitemid 36937164)
62. Mayorga AJ, Lucki I. Limitations on the use of the C57BL/6 mouse in the tail suspension test. Psychopharmacology 2001;155:110-112
63. Redrobe JP, Bourin M. Augmentation of antidepressant pharmacotherapy: a preclinical approach using the mouse forced swimming test. CNS Spectrums 1999;4:73-81.
64. Bourin M, Colombel MC, Malinge M, Bradwejn J. Clonidine as a sensitizing agent in the forced swimming test for revealing antidepressant activity. J Psychiatry Neurosci 1991;16:199-203.
65. De Graaf JS, Van Riezen H, Berendsen HHG, Van Delft AML. A set of behavioural tests predicting antidepressant activity. Current Trends Review 1985;5:291-301.
66. Malinge M, Bourin M, Colombel MC, Larousse C. Additive effects of clonidine and antidepressant drugs in the mouse forcedswimming test. Psychopharmacology (Berl) 1988;96:104-109
67. Devoize JL, Rigal F, Eschalier A, Trolese JF, Renoux M. Influence of naloxone on antidepressant drug effects in the forced swimming test in mice. Psychopharmacology (Berl) 1984;84:71-75
68. Luttinger D, Freedman M, Hamel L, Ward SJ, Perrone M. The effects of serotonin antagonists in a behavioral despair procedure in mice. Eur J Pharmacol 1985;107:53-58
69. Scotto di Tella AM, Mercier J. [Influence of the procedure of administration in the activity of some antidepressant or disinhibiting drugs upon behavioural despair (author's transl)]. J Pharmacol 1981;12:179-188
70. Szymczyk G, Zebrowska-Lupina I. Influence of antiepileptics on efficacy of antidepressant drugs in forced swimming test. Pol J Pharmacol 2000;52:337-344
71. Bourin M, Redrobe JP, Hascoët M, Baker GB, Colombel MC. A schematic representation of the psychopharmacological profile of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2000;20:1389-1402
72. Biziere K, Kan JP, Souilhac J, Muyard JP, Roncucci R. Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug. Arzneimittelforschung 1982;32:824-831
73. Biziere K, Worms P, Kan JP, Mandel P, Garattini S, Roncucci R. Minaprine, a new drug with antidepressant properties. Drugs Exp Clin Res 1985;11:831-840
74. Zocchi A, Varnier G, Arban R, Griffante C, Zanetti L, Bettelini L, Marchi M, Gerrard PA, Corsi M. Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse. Neurosci Lett 2003;345:73-76
75. Mogilnicka E, Czyrak A, Maj J. Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action. Eur J Pharmacol 1987;138:413-416
76. Clenet F, De Vos A, Bourin M. Involvement of 5-HT(2C) receptors in the anti-immobi lity effects of antidepressants in the forced swimming test in mice. Eur Neuropsychopharmacol 2001;11:145-152
77. Stenger A, Couzinier JP, Briley M. Psychopharmacology of midalcipran, 1-phenyl-1- diethyl-amino-carbonyl-2-aminomethylcyclopropane hydrochloride (F 2207), a new potential antidepressant. Psychopharmacology (Berl) 1987;91:147-153
78. Rogoz Z, Skuza G, Maj J. Pharmacological profile of milnacipran, a new antidepressant, given acutely. Pol J Pharmacol 1999;51:317-322
79. Redrobe JP, Bourin M,ColombelMC, Baker GB. Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology (Berl) 1998;138:1-8.
80. Da-Rocha MA, Jr., Puech AJ, Thiébot MH. Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice. J Psychopharmacol 1997;11:211-218
81. Anjaneyulu M, Chopra K, Kaur I. Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice. J Med Food 2003;6:391-395
82. Miura H, Naoi M, Nakahara D, Ohta T, Nagatsu T. Effects of moclobemide on forced-swimming stress and brain monoamine levels in mice. Pharmacol Biochem Behav 1996;53:469-475
83. Kato M, Katayama T, Iwata H, Yamamura M, Matsuoka Y, Narita H. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin. J Pharmacol Exp Ther 1998;284:983-990
84. Eschalier A, Rigal F, Devoize JL, Trolese JF, Grillon C. Morphine pretreatment reduces clomipramine effect in mouse forced-swimming test. Eur J Pharmacol 1983;91:505-507
85. Devoize JL, Rigal F, Eschalier A, Trolese JF. Naloxone inhibits clomipramine in mouse forced swimming test. Eur J Pharmacol 1982;78:229-231
86. Schechter MD, Chance WT. Non-specificity of "behavioral despair" as an animal model of depression. Eur J Pharmacol 1979;60:139-142
87. Machado-Viera R, Kapczinski F, Soares JC. Perspective for the development of animal models of bipolar disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:209-224
88. Nixon M, Bourin M., K., Hascoët M, Colombel MC. Additive effects of the lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotonergic system. Psychopharmacology. 1994;115:59-64.
89. Bourin M, Hascoët M, Colombel MC, Redrobe JP, Baker GB. Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: possible roles of serotonergic system. Eur Neuropsychopharmacol 1996; 6: 231-236
90. Redrobe JP, BourinM. Evidence of the activity of lithium on the 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate. Psychopharmacology 1999;141:370-377
91. Hata T, Itoh E, Nishikawa H. Behavioral characteristics of SART-stressed mice in the forced swim test and drug action. Pharmacol Biochem Behav 1995;51:849-853
92. Overstreet DH, Pucilowski O, Rezvani AH, Janowsky DS. Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology (Berl). 1995;121:27-37.
93. Kitamura Y, Araki H, Gomita Y. Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test. Pharmacol Biochem Behav 2002;71:63-69
94. Wegener G, Bandpey Z, Heiberg IL, Mørk A, Rosenberg R. Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat. Psychopharmacology (Berl) 2003;166:188-194
95. Mague SM, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC, Jones RM, Portoghese PS, Carlezon Jr. W.A. Antidepressant-like effects of -opioid receptor antagonists in the forced swim test in rats. J Pharmacol ExpTher 2003;305:1-8.
96. Carlezon Jr WA, Beguin C, DiNieri J, Baumann MH, Richards M, Todtenkopf MS, Rothman RB, Ma Z, Lee DY-L, Cohen BM. Depressive-like effects of the-opioid receptor agonist Salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 2006;314:440-447
97. O'Donnell KC, Gould TD. The behavioral actions of lithium in rodent models: leads to develop novel therapeutics. Neurosci Biobehav Rev 2007;31:932-962
98. Mac Donald R L, Rogers C J, Twyman R E. Barbiturate regulation of kinetic properties of the GABAA receptor channel of mouse spinal neurons in culture. J Physiol 1989;417:483-500.
99. Post RM, Uhde TW, Roy-Byrne PP, Joffe RT. Antidepressant effects of carbamazepine. Am J Psychiatry 1986;143:29-34.
100. Post RM, Weiss SR, Chuang DM. Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium. J Clin Psychopharmacol. 1992;12:23S-35S.
101. Bourin M, Masse F, Hascoët M. Evidence for the activity of lamotrigine at 5-HT1A receptors in the mouse forced swimming test. J PsychiatryNeurosci 2005;30:275-282
102. Leach MJ, Marden CM, Miller AA. Pharmacological studies of lamotrigine, a novel potential antipsychotic drug: neurochemical and clinical studies of the mechanism of action. Epilepsia 1986;27:490-497
103. Kuo CC, Lu L. Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurons. Br J Pharmacol 1997;121:1231-1238
104. Lizasoain I, Knowles RG, Moncada S. Inhibition by lamotrigine of the generation of nitric oxide in rat forebrain slices. J Neurochem 1995;64:636-642
105. Prica C, Hascoët M, Bourin M. Antidepressant- like effect of lamotrigine is reversed by veratrine: a possible role of sodium channels in bipolar depression. Behav Brain Res. 2008;191:49-54.
106. Renard CE, Dailly E, David DJ, Hascoët M. Bourin M. Neurochemical changes following the mouse forced swimming test but not the tail suspension test. Fundam Clin Pharmacol 2003;17:449-455
107. Cooper BR, Hester TJ, Maxwell RA. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J Pharmacol Exp Ther 1980;215:127-134
108. Meyer JH, Goulding VS,Wilson AA, Hussey D, Christensen B.K, Houle S. Bupropion occupancy of the dopamine transporter is low during clinical treatment. Psychopharmacology (Berl) 2002;163:102-105
109. Dong J and Blier P. Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment. Psychopharmacology (Berl) 2001;155:52-57
110. Wong ML, Licinio J. From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov 2002;3:136-151